Matt Winton serves as the Chief Commercial and Business Officer at CervoMed since October 2025. Previously, Matt held the position of Chief Operating Officer at Inozyme Pharma from April 2023 to September 2025, where Matt played a key role in the company's acquisition by BioMarin Pharmaceuticals. Matt's extensive experience at Biogen spanned nearly nine years, culminating in the role of Senior Vice President, Head of US MS Franchise, where annual revenue exceeded $3 billion. Prior roles at Biogen included leadership in the US Spinal Muscular Atrophy Franchise and strategic advisement to the CEO. Matt has also held positions at inVentiv Health and Decision Resources Group and has foundational experience in market access and consulting within the life sciences industry. Academic qualifications include a PhD in Pathology and Cell Biology from Université de Montréal and an MBA focused on Health Sector Management from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices